You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表现》圣诺医药(02257.HK)暗盘低开近9%报60元
根据辉立交易平台显示,明天挂牌的圣诺医药-B(02257.HK)暗盘低开近9%报60元获承接,掉头曾高见68元,现报60.3元,较上市价65.9元,低8.5%,成交1,140股。 圣诺是一家核糖核酸(RNA)疗法生物制药公司。是次在港上市共发售754万股,并已引入昆明佳时清及健新原力制药为基石投资者,合共认购338.28万股;其中10%公开发售获约4.68倍超购,认购一手中签率21.77%,股份以招股范围(65.9-72.7元)下限定价,料集资净额约3.96亿元,主要用于发展及商业化公司核心产品STP705、用于STP707开发、拨付GalNAc计划产品、其他临床前阶段候选产品,以及其他临床前候选药物研发等。上市独家保荐人中金。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account